Emma Andrus, Editor

Christopher Bunick, MD, PhD, discusses key differences in AD biologics and challenges in achieving optimal treatment targets.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Integrating molecular testing into melanoma and SCC management enhances risk assessment and personalizes treatment, revolutionizing patient care in dermatology.

Thiamidol emerges as a promising treatment for hyperpigmentation, showcasing superior efficacy and safety compared to traditional options like hydroquinone.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

ZEVASKYN, the first FDA-approved gene therapy for wounds in recessive dystrophic epidermolysis bullosa, is now available at Lurie Children's Hospital.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

The new partnership brings RNA-targeted innovation to dermatology-relevant disease areas like autoimmunity and cancer.

Extended oral corticosteroid therapy in patients with atopic dermatitis significantly increases cardiovascular and thrombotic risks, urging careful treatment evaluations.

This review of the latest dermatologic studies includes insights into switching PD-1 to BRAF + MEK inhibition, clinical outcomes and prognosis in atypical fibroxanthoma, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Researchers reveal TRIV-509, a novel monoclonal antibody, shows promise in rapidly improving atopic dermatitis by restoring skin barrier integrity and reducing inflammation.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Seven dermatologists have received GLODERM x CeraVe Access Grants to expand skin care access in underserved communities worldwide.

Christopher Bunick, MD, PhD, explains why composite endpoints are now critical for evaluating patient outcomes in AD therapy.

Explore the evolving landscape of dermatology as experts emphasize the importance of cross-specialty collaboration and patient-centered care in aesthetic medicine.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!

Explore the evolving landscape of dermatology as experts emphasize the importance of cross-specialty collaboration and patient-centered care in aesthetic medicine.

Desai reflects on his AAD presidency, addressing Medicare challenges, technological advancements, and the future of dermatology leadership.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

We review survey data revealing diagnostic confusion, treatment gaps, and the emotional, social, and occupational toll of moderate to severe chronic hand eczema.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This review of the latest dermatologic studies includes insights into short- and long-term effects of topical cosmetics to dermatological procedures, adverse effects of omalizumab in urticaria, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Researchers reported that upadacitinib may lower the incidence of major cardiovascular events and venous thromboembolism in AD.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This Melanoma Monday, we take a look at melanoma care in the US, from treatments to persistent gaps in access, early detection, and long-term outcomes.